{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:44:37Z","timestamp":1792676677851,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.pbb.2015.10.004","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T19:15:28Z","timestamp":1445282128000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PA","title":["Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol"],"prefix":"10.1016","volume":"139","author":[{"given":"Nishant S.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshyapati","family":"Tandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.10.004_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1472-8206.2006.00411.x","article-title":"Antipsychotic like profile of thioperamide, a selective H3-receptor antagonist in mice","volume":"20","author":"Akhtar","year":"2006","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.004_bb0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","article-title":"Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade","volume":"51","author":"Arnt","year":"1982","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"1","key":"10.1016\/j.pbb.2015.10.004_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archpsyc.1988.01800250095013","article-title":"Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses","volume":"45","author":"Baldessarini","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2015.10.004_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00426037","article-title":"Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy","volume":"62","author":"Balsara","year":"1979","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.004_bb0025","series-title":"A Primer of Behavioral Pharmacology In. Concepts and Principles in the Behavioral Analysis of Drug Action","author":"Carlton","year":"1983"},{"key":"10.1016\/j.pbb.2015.10.004_bb0030","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0024-3205(98)00154-4","article-title":"Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system","volume":"62","author":"Chiavegatto","year":"1998","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.pbb.2015.10.004_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00439266","article-title":"The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat","volume":"81","author":"Clark","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2015.10.004_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0091-3057(94)00397-2","article-title":"Catalepsy Fos protein and dopamine receptor occupancy after long-term haloperidol treatment","volume":"51","author":"Coppens","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.004_bb0045","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0024-3205(76)90205-8","article-title":"Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats","volume":"18","author":"Davidson","year":"1976","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2015.10.004_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/PL00005274","article-title":"Increased levels of extracellular dopamine in neostriatum and nucleus accumbens after histamine H1 receptor blockade","volume":"358","author":"Dringenberg","year":"1998","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(93)90036-D","article-title":"Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic of drugs","volume":"57","author":"Ellenbroek","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2015.10.004_bb0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(00)00608-7","article-title":"Influence of different histamine receptor agonists and antagonists on apomorphine-induced licking behavior in rat","volume":"404","author":"Farzin","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0091-3057(02)00748-7","article-title":"Rodent antinociception following acute treatment with different histamine receptor agonists and antagonists","volume":"72","author":"Farzin","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.004_bb0070","doi-asserted-by":"crossref","unstructured":"Fell J Matthew, Katner S Jason, Rasmussen Kurt, Nikolayev Alexander, Kuo Ming-Shang, Nelson L.G. David, Perry W Kenneth, Svensson A. Kjell. Typical and atypical antipsychotic drugs increase extracellular histamine levels in the rat medial prefrontal cortex: contribution of histamine H1 receptor blockade. Front. Psychiatry 2012, 17 May; http:\/\/dx.doi.org\/10.3389\/fpsyt.2012.00049","DOI":"10.3389\/fpsyt.2012.00049"},{"key":"10.1016\/j.pbb.2015.10.004_bb0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2011.01.018","article-title":"Antipsychotic-induced catalepsy is attenuated in mice lacking the M4-muscarinic acetylcholine receptor","volume":"656","author":"Fink-Jensen","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/S0100-879X2009000100019","article-title":"l-histidine reduces inhibitory avoidance in Carassius auratus submitted to cerebellar ablation","volume":"42","author":"Garcao","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0085","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"issue":"2\u20133","key":"10.1016\/j.pbb.2015.10.004_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2003.11.006","article-title":"Alleviation of ischemic neuronal damage by histamine H2 receptor stimulation in the rat striatum","volume":"484","author":"Hamami","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0095","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/0024-3205(90)90365-X","article-title":"The effect of serotonergic agents on haloperidol-induced catalepsy","volume":"47","author":"Hicks","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2015.10.004_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","article-title":"International union of pharmacology: XIII. Classification of histamine receptors","volume":"49","author":"Hill","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2015.10.004_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pbb.2012.08.006","article-title":"Somatostatin antagonist potentiates haloperidol induced catalepsy in the aged rat","volume":"103","author":"Ionov","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.004_bb0110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/mds.23069","article-title":"Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease","volume":"25","author":"Johnston","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.pbb.2015.10.004_bb0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1124\/jpet.111.187443","article-title":"The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease","volume":"340","author":"Jones","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.004_bb0120","first-page":"293","article-title":"Effect of l-histidine pretreatment on haloperidol induced catalepsy and methamphetamine stereotypy in mice","volume":"11","author":"Joshi","year":"1979","journal-title":"Ind. J. Pharmac."},{"key":"10.1016\/j.pbb.2015.10.004_bb0125","first-page":"1","article-title":"Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection","volume":"4","author":"Lieberman","year":"2006","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pbb.2015.10.004_bb0130","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.neuropharm.2007.08.014","article-title":"Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"53","author":"Liu","year":"2007","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2015.10.004_bb0135","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0031-1301326","article-title":"Reversal of oxidative stress by histamine H3 receptor-ligands in experimental models of schizophrenia","volume":"62","author":"Mahmood","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pbb.2015.10.004_bb0140","first-page":"293","article-title":"The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol","volume":"35","author":"Malec","year":"1983","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"10.1016\/j.pbb.2015.10.004_bb0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2010.06.020","article-title":"Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy","volume":"1349","author":"Melo","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0091-3057(95)02014-4","article-title":"Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice","volume":"53","author":"Mizuki","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.004_bb0155","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0022-3565(24)37994-7","article-title":"Atypical neuroleptics enhance histamine turnover in brain via 5 HT2A receptor blockade","volume":"288","author":"Morisset","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2015.10.004_bb0160","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/jpet.300.2.621","article-title":"Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D2 and not D3 receptor","volume":"300","author":"Morisset","year":"2002","journal-title":"JPET"},{"key":"10.1016\/j.pbb.2015.10.004_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.2042-7158.1982.tb04673.x","article-title":"Involvement of histaminergic mechanisms in the cataleptogenic effect of morphine in mice","volume":"34","author":"Muley","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0170","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-3223(91)90290-3","article-title":"Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia","volume":"30","author":"Nakai","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.10.004_bb0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)38100-0","article-title":"Serotonergic involvement in haloperidol-induced catalepsy","volume":"265","author":"Neal-Beliveau","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2015.10.004_bb0180","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1530\/acta.0.1190488","article-title":"Further evidence that brain histamine H2 receptors are stimulatory in the control of prolactin in the rat","volume":"119","author":"Netti","year":"1988","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.pbb.2015.10.004_bb0185","first-page":"466","article-title":"Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene","volume":"1","author":"Orange","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2015.10.004_bb0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(03)02558-7","article-title":"Blockade of central histaminergic H2 receptors facilitates catecholaminergic metabolism and aggravates ischemic brain damage in the rat telencephalon","volume":"6","author":"Otsuka","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0195","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.pbb.2015.10.004_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/15376516.2011.610383","article-title":"Co-administration of haloperidol and drugs affecting the angiotensin pathway: effect on the extrapyramidal system","volume":"22","author":"Pemminati","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.pbb.2015.10.004_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0306-4522(02)00135-5","article-title":"A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain","volume":"14","author":"Pillot","year":"2002","journal-title":"Neuroscience1"},{"key":"10.1016\/j.pbb.2015.10.004_bb0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0920-9964(94)00034-6","article-title":"Histamine metabolites in cerebrospinalfluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms","volume":"14","author":"Prell","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0215","first-page":"44","article-title":"Cutaneous histamine response in schizophrenia","volume":"41","author":"Rauscher","year":"1980","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2015.10.004_bb0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0924-977X(02)00021-4","article-title":"Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2","volume":"12","author":"Rehavi","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2015.10.004_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ddr.430170202","article-title":"Effects of H2-receptor antagonists on the central nervous system","volume":"17","author":"Roger","year":"1989","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-3806(95)00055-I","article-title":"Ontogenetic development of histamine receptor subtypes in rat brain demonstrated by quantitative autoradiography","volume":"87","author":"Ryu","year":"1995","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0301-0082(97)00011-7","article-title":"Role of the central histaminergic neuronal system in the CNS toxicity of the first generation H-antagonists","volume":"52","author":"Sangalli","year":"1997","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.pbb.2015.10.004_bb0240","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1472-8206.1994.tb00789.x","article-title":"Modulation of neurotransmitter release via histamine H3 heteroreceptors","volume":"8","author":"Schlicker","year":"1994","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0245","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0925-4927(97)00044-9","article-title":"[123I] IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects","volume":"75","author":"Schlosser","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2015.10.004_bb0250","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-2999(71)90035-5","article-title":"Catabolism of 3H-histamine in the rat brain after intracisternal administration","volume":"16","author":"Schwartz","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1991.71.1.1","article-title":"Histaminergic transmission in the mammalian brain","volume":"71","author":"Schwartz","year":"1991","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.pbb.2015.10.004_bb0260","series-title":"Histamine, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer, Eds), pp 397\u2013405","author":"Schwartz","year":"1995"},{"key":"10.1016\/j.pbb.2015.10.004_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2015.10.004_bb0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-2999(77)90126-1","article-title":"Modulation by histamine of the efflux of radiolabelled catecholamines from rat brain slices","volume":"43","author":"Subramanian","year":"1977","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.pbb.2015.10.004_bb0275","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/0024-3205(85)90031-1","article-title":"The effects of histamine and some related compounds on conditioned avoidance response in rats","volume":"37","author":"Tasaka","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2015.10.004_bb0280","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pnpbp.2012.04.008","article-title":"Modulation of antipsychotic-induced extrapyramidal side effects by medications for mood disorders","volume":"38","author":"Tatara","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2015.10.004_bb0285","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.npep.2009.03.002","article-title":"A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol","volume":"43","author":"Umathe","year":"2009","journal-title":"Neuropeptides"},{"issue":"3","key":"10.1016\/j.pbb.2015.10.004_bb0290","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/138161210790170085","article-title":"Conditioned avoidance response in the development of new antipsychotics","volume":"16","author":"Wadenberg","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2015.10.004_bb0295","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.pbb.2006.06.010","article-title":"Differently lasting effects of prenatal and postnatal chronic clozapine\/haloperidol on activity and memory in mouse offspring","volume":"84","author":"Wang","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.10.004_bb0300","first-page":"17","article-title":"Brain histamine and neuroleptic-induced catalepsy","volume":"44","author":"Yagi","year":"1992","journal-title":"Med. J. Osaka Univ."},{"key":"10.1016\/j.pbb.2015.10.004_bb0305","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1113\/jphysiol.2010.203257","article-title":"L-Dopa activates histaminergic neurons","volume":"589","author":"Yanovsky","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.pbb.2015.10.004_bb0310","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0024-3205(85)90293-0","article-title":"Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice","volume":"37","author":"Yurek","year":"1985","journal-title":"Life Sci."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T22:26:46Z","timestamp":1748644006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715300769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":62,"alternative-id":["S0091305715300769"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.004","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of the central histaminergic transmission in the cataleptic and neuroleptic effects of haloperidol","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}